Prof Paul Monagle

MBBS MD MSc FRACP FRCPA FCCP
The University of Melbourne

Prof Paul Monagle is Professor Paediatrics, The University of Melbourne; Chief Paediatric and Perinatal Pathologist, Public Pathology Victoria- MH; and Co-Group leader Haematology Research, Murdoch Children’s Research Institute.

He is a past Stevenson Chair and Head of Department of Paediatrics, The University of Melbourne (2008-2016); Head Department Pathology, The University of Melbourne (2005-2008); Director of Laboratory Services Royal Children’s Hospital Melbourne (2000-2005), Head of Clinical Haematology (1998-2010), and Acting Head of Children’s Cancer Centre Royal Children’s Hospital (RCH)(2010-2012).  

Prof Monagle is also a past chair of the paediatric/perinatal Scientific Subcommittee of ISTH; leader paediatric chapter of the ACCP antithrombotic guidelines for over a decade; member of the NIH working party into thrombotic disorders in paediatric cardiology patients; member of the ASH venous thrombosis guideline steering committee, and chair of the paediatric panel.  

He has co-authored multiple textbooks; 50 chapters in major international textbooks; over 430 publications, with over 10000 citations.  He has supervised 15 PhD students to completion, and has been involved in education, advocacy and fund raising at multiple levels locally, nationally and internationally.

Prof Monagle was a member of CCOPMM (Consultative Council of Obstetric and Paediatric Morbidity and Mortality) (2008-2021), and chaired the child and adolescent subcommittee(2015-2021). CCOPMM is a statutory body that reviews all maternal, neonatal, and child deaths in Victoria and reports directly to the health minister. He is a current member of the ASH haemostasis and thrombosis working group and the ISTH guidelines and guidance committees.

Prof Monagle's major research interests include the natural history and diagnosis of VTE in children, the pharmacology of anticoagulants in children, clinical trials of anticoagulants, optimal use of laboratory monitoring of anticoagulants in children, developmental haemostasis and coagulation biology, developing normative laboratory data, and anticoagulation in the setting of artificial circuits.

Articles featuring

Prof Paul Monagle

Read our latest news

Meet more people

Commitee members who have been directly affected by childhood cancer
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.
Dev Note:
This slider will be replaced by the cards above in the published site.

Get Involved

CoLaborate with us to accelerate childhood cancer research and innovation

Patient Stories
Collaboration
Innovation Accelerators
Survivorship and Living Well
Future Leaders
Safer Therapies
Next-Generation Therapies
Transformative Therapies
Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship
Future Leaders
Innovation Accelerators
Survivorship and Living Well
Transformative Therapies